{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:35:33Z","timestamp":1790393733525,"version":"4.1.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T00:00:00Z","timestamp":1444089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0139871","type":"journal-article","created":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T13:57:24Z","timestamp":1444139844000},"page":"e0139871","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Anti-IL-20 Monoclonal Antibody Suppresses Prostate Cancer Growth and Bone Osteolysis in Murine Models"],"prefix":"10.1371","volume":"10","author":[{"given":"Yu-Hsiang","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Hsi","family":"Hsing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ting","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Wha","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Shi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,10,6]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.canep.2014.06.002","article-title":"Sexually transmitted infections and prostate cancer risk: A systematic review and meta-analysis","volume":"38","author":"S Caini","year":"2014","journal-title":"Cancer epidemiology"},{"issue":"12 Suppl","key":"ref2","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1002\/1097-0142(20000615)88:12+<2989::AID-CNCR14>3.0.CO;2-Q","article-title":"The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma","volume":"88","author":"BI Carlin","year":"2000","journal-title":"Cancer"},{"issue":"2","key":"ref3","first-page":"99","article-title":"Managing bone loss and bone metastases in prostate cancer patients: a focus on bisphosphonate therapy","volume":"10","author":"RS Israeli","year":"2008","journal-title":"Reviews in urology"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1158\/1535-7163.MCT-07-0234","article-title":"Molecular biology of bone metastasis","volume":"6","author":"LA Kingsley","year":"2007","journal-title":"Molecular cancer therapeutics"},{"issue":"11","key":"ref5","first-page":"1537","article-title":"Pain management in patients with advanced prostate cancer","volume":"13","author":"KB Olson","year":"1999","journal-title":"Oncology"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1172\/JCI11685","article-title":"Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone","volume":"107","author":"J Zhang","year":"2001","journal-title":"The Journal of clinical investigation"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1586\/era.12.177","article-title":"Targeting RANKL in breast cancer: bone metastasis and beyond","volume":"13","author":"H Azim","year":"2013","journal-title":"Expert review of anticancer therapy"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"GR Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1359\/jbmr.2003.18.2.222","article-title":"Cathepsin K mRNA and protein expression in prostate cancer progression. Journal of bone and mineral research: the official journal of the","volume":"18","author":"KD Brubaker","year":"2003","journal-title":"American Society for Bone and Mineral Research"},{"issue":"14","key":"ref10","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1158\/0008-5472.CAN-07-5889","article-title":"Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand","volume":"68","author":"TJ Wilson","year":"2008","journal-title":"Cancer Res"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1084\/jem.186.5.739","article-title":"Identification of human neutrophil-derived cathepsin G and azurocidin\/CAP37 as chemoattractants for mononuclear cells and neutrophils","volume":"186","author":"O Chertov","year":"1997","journal-title":"J Exp Med"},{"issue":"20","key":"ref12","doi-asserted-by":"crossref","first-page":"9894","DOI":"10.1158\/0008-5472.CAN-06-3940","article-title":"A cathepsin K inhibitor reduces breast cancer induced osteolysis and skeletal tumor burden","volume":"67","author":"C Le Gall","year":"2007","journal-title":"Cancer Res"},{"issue":"6917","key":"ref13","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"LM Coussens","year":"2002","journal-title":"Nature"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cytogfr.2006.07.002","article-title":"Cytokines in breast cancer","volume":"17","author":"A Nicolini","year":"2006","journal-title":"Cytokine & growth factor reviews"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2001-1326-3-23","article-title":"Biomechanics of TGFbeta-induced epithelial-mesenchymal transition: implications for fibrosis and cancer","volume":"3","author":"JW O'Connor","year":"2014","journal-title":"Clinical and translational medicine"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"JP Thiery","year":"2009","journal-title":"Cell"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1158\/0008-5472.CAN-12-3979","article-title":"Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer","volume":"73","author":"M Shiota","year":"2013","journal-title":"Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M113.527267","article-title":"Inhibition of Epithelial to Mesenchymal transition by E-cadherin up-regulation via repression of Slug transcription and inhibition of E-cadherin degradation: Dual role of SMAR1 in breast cancer cells","author":"A Adhikary","year":"2014","journal-title":"The Journal of biological chemistry"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1158\/1541-7786.MCR-11-0271","article-title":"IL\u20136 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway","volume":"9","author":"A Yadav","year":"2011","journal-title":"Molecular cancer research: MCR"},{"issue":"33","key":"ref20","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1038\/onc.2009.180","article-title":"Interleukin\u20136 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells","volume":"28","author":"NJ Sullivan","year":"2009","journal-title":"Oncogene"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cytogfr.2010.11.001","article-title":"IL\u201310 family of cytokines","volume":"21","author":"R Sabat","year":"2010","journal-title":"Cytokine & growth factor reviews"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1146\/annurev.immunol.22.012703.104622","article-title":"Interleukin\u201310 and related cytokines and receptors","volume":"22","author":"S Pestka","year":"2004","journal-title":"Annual review of immunology"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.4049\/jimmunol.167.7.3545","article-title":"Cutting edge: STAT activation by IL\u201319, IL\u201320 and mda\u20137 through IL\u201320 receptor complexes of two types","volume":"167","author":"L Dumoutier","year":"2001","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1002\/art.22039","article-title":"Function of interleukin\u201320 as a proinflammatory molecule in rheumatoid and experimental arthritis","volume":"54","author":"YH Hsu","year":"2006","journal-title":"Arthritis and rheumatism"},{"issue":"9","key":"ref25","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1161\/01.ATV.0000232502.88144.6f","article-title":"IL\u201320 is expressed in atherosclerosis plaques and promotes atherosclerosis in apolipoprotein E-deficient mice","volume":"26","author":"WY Chen","year":"2006","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.clim.2005.06.012","article-title":"Detection of IL\u201320 and its receptors on psoriatic skin","volume":"117","author":"CC Wei","year":"2005","journal-title":"Clinical immunology (Orlando, Fla)"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0092-8674(01)00187-8","article-title":"Interleukin 20: discovery, receptor identification, and role in epidermal function","volume":"104","author":"H Blumberg","year":"2001","journal-title":"Cell"},{"issue":"9","key":"ref28","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1084\/jem.20102234","article-title":"Anti-IL\u201320 monoclonal antibody inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss","volume":"208","author":"YH Hsu","year":"2011","journal-title":"J Exp Med"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1158\/1541-7786.MCR-12-0276","article-title":"Anti-IL\u201320 monoclonal antibody alleviates inflammation in oral cancer and suppresses tumor growth","volume":"10","author":"YH Hsu","year":"2012","journal-title":"Molecular cancer research: MCR"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.4049\/jimmunol.1102843","article-title":"Anti-IL\u201320 monoclonal antibody suppresses breast cancer progression and bone osteolysis in murine models","volume":"188","author":"YH Hsu","year":"2012","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.bbrc.2008.07.039","article-title":"Interleukin\u201320 targets renal cells and is associated with chronic kidney disease","volume":"374","author":"CC Wei","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"ref32","first-page":"3545","article-title":"Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer","volume":"50","author":"RA McClelland","year":"1990","journal-title":"Cancer Res"},{"issue":"5\u20136","key":"ref33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.semcancer.2012.05.003","article-title":"The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity","volume":"22","author":"MA Nieto","year":"2012","journal-title":"Seminars in cancer biology"},{"issue":"8","key":"ref34","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1074\/jbc.M112.410233","article-title":"Interleukin\u201320 promotes migration of bladder cancer cells through extracellular signal-regulated kinase (ERK)-mediated MMP\u20139 protein expression leading to nuclear factor (NF-kappaB) activation by inducing the up-regulation of p21(WAF1) protein expression","volume":"288","author":"SJ Lee","year":"2013","journal-title":"The Journal of biological chemistry"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2174\/1566524011313040012","article-title":"Understanding and targeting osteoclastic activity in prostate cancer bone metastases","volume":"13","author":"JL Sottnik","year":"2013","journal-title":"Current molecular medicine"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ctrv.2014.04.003","article-title":"Recent advances in bone-targeted therapies of metastatic prostate cancer","volume":"40","author":"X Deng","year":"2014","journal-title":"Cancer treatment reviews"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1158\/1541-7786.MCR-09-0028","article-title":"Cathepsin G-mediated activation of pro-matrix metalloproteinase 9 at the tumor-bone interface promotes transforming growth factor-beta signaling and bone destruction","volume":"7","author":"TJ Wilson","year":"2009","journal-title":"Molecular cancer research: MCR"},{"issue":"7","key":"ref38","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1158\/0008-5472.CAN-08-1956","article-title":"Cathepsin G recruits osteoclast precursors via proteolytic activation of protease-activated receptor\u20131","volume":"69","author":"TJ Wilson","year":"2009","journal-title":"Cancer Res"},{"issue":"7084","key":"ref39","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature04524","article-title":"Regulation of cancer cell migration and bone metastasis by RANKL","volume":"440","author":"DH Jones","year":"2006","journal-title":"Nature"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/pros.20678","article-title":"RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes","volume":"68","author":"AP Armstrong","year":"2008","journal-title":"The Prostate"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","article-title":"A multigenic program mediating breast cancer metastasis to bone","volume":"3","author":"Y Kang","year":"2003","journal-title":"Cancer cell"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10585-011-9438-0","article-title":"Analysis of a bone metastasis gene expression signature in patients with bone metastasis from solid tumors","volume":"29","author":"S Casimiro","year":"2012","journal-title":"Clinical & experimental metastasis"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1089\/cbr.2007.0453","article-title":"Recombinant human IL\u201324 suppresses lung carcinoma cell growth via induction of cell apoptosis and inhibition of tumor angiogenesis","volume":"23","author":"Y Xie","year":"2008","journal-title":"Cancer Biother Radiopharm"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-4471-6458-6_6","article-title":"MDA\u20137\/IL\u201324: multifunctional cancer killing cytokine","volume":"818","author":"ME Menezes","year":"2014","journal-title":"Advances in experimental medicine and biology"},{"issue":"6","key":"ref45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.cytogfr.2012.08.004","article-title":"Interleukin 24: mechanisms and therapeutic potential of an anti-cancer gene","volume":"23","author":"EL Whitaker","year":"2012","journal-title":"Cytokine & growth factor reviews"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0139871","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T20:24:47Z","timestamp":1540499087000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0139871"}},"subtitle":[],"editor":[{"given":"Dominique","family":"Heymann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,6]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0139871","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,6]]}}}